Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine

M. Joerger, J. A. Burgers, P. Baas, V. D. Doodeman, P. H. M. Smits, R. S. Jansen, L. D. Vainchtein, H. Rosing, A. D. R. Huitema, J. H. Beijnen, J. H. M. Schellens
  • Cancer Chemotherapy and Pharmacology, May 2011, Springer Science + Business Media
  • DOI: 10.1007/s00280-011-1670-4

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s00280-011-1670-4

The following have contributed to this page: Robert Jansen

In partnership with: